These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 2749729

  • 1. Physiologically based pharmacokinetic modeling of the pregnant rat: a multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid.
    Fisher JW, Whittaker TA, Taylor DH, Clewell HJ, Andersen ME.
    Toxicol Appl Pharmacol; 1989 Jul; 99(3):395-414. PubMed ID: 2749729
    [Abstract] [Full Text] [Related]

  • 2. Physiologically based pharmacokinetic modeling of the lactating rat and nursing pup: a multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid.
    Fisher JW, Whittaker TA, Taylor DH, Clewell HJ, Andersen ME.
    Toxicol Appl Pharmacol; 1990 Mar 01; 102(3):497-513. PubMed ID: 2315918
    [Abstract] [Full Text] [Related]

  • 3. Physiologically based pharmacokinetic modeling with trichloroethylene and its metabolite, trichloroacetic acid, in the rat and mouse.
    Fisher JW, Gargas ML, Allen BC, Andersen ME.
    Toxicol Appl Pharmacol; 1991 Jun 15; 109(2):183-95. PubMed ID: 2068722
    [Abstract] [Full Text] [Related]

  • 4. A physiologically based pharmacokinetic model for trichloroethylene and its metabolites, chloral hydrate, trichloroacetate, dichloroacetate, trichloroethanol, and trichloroethanol glucuronide in B6C3F1 mice.
    Abbas R, Fisher JW.
    Toxicol Appl Pharmacol; 1997 Nov 15; 147(1):15-30. PubMed ID: 9356303
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetic modeling of trichloroethylene and trichloroacetic acid in humans.
    Allen BC, Fisher JW.
    Risk Anal; 1993 Feb 15; 13(1):71-86. PubMed ID: 8451462
    [Abstract] [Full Text] [Related]

  • 6. Physiologically based pharmacokinetic modeling of inhaled trichloroethylene and its oxidative metabolites in B6C3F1 mice.
    Greenberg MS, Burton GA, Fisher JW.
    Toxicol Appl Pharmacol; 1999 Feb 01; 154(3):264-78. PubMed ID: 9931286
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Physiologically based pharmacokinetic models for trichloroethylene and its oxidative metabolites.
    Fisher JW.
    Environ Health Perspect; 2000 May 01; 108 Suppl 2(Suppl 2):265-73. PubMed ID: 10807557
    [Abstract] [Full Text] [Related]

  • 11. A human physiologically based pharmacokinetic model for trichloroethylene and its metabolites, trichloroacetic acid and free trichloroethanol.
    Fisher JW, Mahle D, Abbas R.
    Toxicol Appl Pharmacol; 1998 Oct 01; 152(2):339-59. PubMed ID: 9853003
    [Abstract] [Full Text] [Related]

  • 12. Development of an updated PBPK model for trichloroethylene and metabolites in mice, and its application to discern the role of oxidative metabolism in TCE-induced hepatomegaly.
    Evans MV, Chiu WA, Okino MS, Caldwell JC.
    Toxicol Appl Pharmacol; 2009 May 01; 236(3):329-40. PubMed ID: 19249323
    [Abstract] [Full Text] [Related]

  • 13. A physiologically based pharmacokinetic model for trichloroethylene in the male long-evans rat.
    Simmons JE, Boyes WK, Bushnell PJ, Raymer JH, Limsakun T, McDonald A, Sey YM, Evans MV.
    Toxicol Sci; 2002 Sep 01; 69(1):3-15. PubMed ID: 12215655
    [Abstract] [Full Text] [Related]

  • 14. Trichloroethylene in drinking water throughout gestation did not produce congenital heart defects in Sprague Dawley rats.
    DeSesso JM, Coder PS, York RG, Budinsky RA, Pottenger LH, Sen S, Lucarell JM, Bevan C, Bus JS.
    Birth Defects Res; 2019 Oct 01; 111(16):1217-1233. PubMed ID: 31197966
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetic analysis of trichloroethylene metabolism in male B6C3F1 mice: Formation and disposition of trichloroacetic acid, dichloroacetic acid, S-(1,2-dichlorovinyl)glutathione and S-(1,2-dichlorovinyl)-L-cysteine.
    Kim S, Kim D, Pollack GM, Collins LB, Rusyn I.
    Toxicol Appl Pharmacol; 2009 Jul 01; 238(1):90-9. PubMed ID: 19409406
    [Abstract] [Full Text] [Related]

  • 16. Tissue dosimetry expansion and cross-validation of rat and mouse physiologically based pharmacokinetic models for trichloroethylene.
    Keys DA, Bruckner JV, Muralidhara S, Fisher JW.
    Toxicol Sci; 2003 Nov 01; 76(1):35-50. PubMed ID: 12915716
    [Abstract] [Full Text] [Related]

  • 17. Quantitative evaluation of the metabolic interactions between trichloroethylene and 1,1-dichloroethylene in vivo using gas uptake methods.
    Andersen ME, Gargas ML, Clewell HJ, Severyn KM.
    Toxicol Appl Pharmacol; 1987 Jun 30; 89(2):149-57. PubMed ID: 3603553
    [Abstract] [Full Text] [Related]

  • 18. A trichloroethylene risk assessment using a Monte Carlo analysis of parameter uncertainty in conjunction with physiologically-based pharmacokinetic modeling.
    Cronin WJ, Oswald EJ, Shelley ML, Fisher JW, Flemming CD.
    Risk Anal; 1995 Oct 30; 15(5):555-65. PubMed ID: 7501875
    [Abstract] [Full Text] [Related]

  • 19. Evaluating the risk of liver cancer in humans exposed to trichloroethylene using physiological models.
    Fisher JW, Allen BC.
    Risk Anal; 1993 Feb 30; 13(1):87-95. PubMed ID: 8451463
    [Abstract] [Full Text] [Related]

  • 20. Physiologically based pharmacokinetic modeling with dichloromethane, its metabolite, carbon monoxide, and blood carboxyhemoglobin in rats and humans.
    Andersen ME, Clewell HJ, Gargas ML, MacNaughton MG, Reitz RH, Nolan RJ, McKenna MJ.
    Toxicol Appl Pharmacol; 1991 Mar 15; 108(1):14-27. PubMed ID: 1900959
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.